Interestingly, most cancer cells overexpress SLC7A11 (22), suggesting a strong dependence on GSH to maintain the levels of controlled reactive oxygen species (ROS) (Figure 1B); thus, SLC7A11 is an potential therapeutic target. Here, SLC7A11 is linked to cancer.